All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Nymox Pharmaceutical Corporation market cap

Nymox Pharmaceutical Corporation volume of trade today and historical data of Nymox Pharmaceutical Corporation capitalization since start date of trade of NYMX stocks.
Add to widgets
Added to widgets

Nymox Pharmaceutical Corporation capitalization

Today's market capitalization for Nymox Pharmaceutical Corporation is 40 731 796 US dollar.
+1 810 300 $ (+4.65%)
change of capitalization since yesterday

The sum of all Nymox Pharmaceutical Corporation stock quotes issued today is the capitalization of Nymox Pharmaceutical Corporation stock quote. Our website takes information of Nymox Pharmaceutical Corporation capitalization for today from open sources. Based on the trading of stock quote Nymox Pharmaceutical Corporation on stock exchange market, you can evaluate the capitalization of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation market cap today is $ 40 731 796.

Nymox Pharmaceutical Corporation volume of trade

Today's Nymox Pharmaceutical Corporation volume of trade is 2 034 US dollar.
-90 973 $ (-97.81%)
change of volume of trade since yesterday

Nymox Pharmaceutical Corporation trading volume today is 2 034 US dollars. Nymox Pharmaceutical Corporation is traded on different stock exchanges. Nymox Pharmaceutical Corporation trading online helds on most online stock exchanges, our website shows the total trading volume of Nymox Pharmaceutical Corporation per day. Nymox Pharmaceutical Corporation capitalization has increased by $ 1 810 300.

Show:
to

Nymox Pharmaceutical Corporation market cap chart

Nymox Pharmaceutical Corporation market cap chart by years. -2.17% per week - a change in the market capitalization of Nymox Pharmaceutical Corporation. Over the year, Nymox Pharmaceutical Corporation capitalization has changed by 0%. Today, Nymox Pharmaceutical Corporation capitalization is estimated at 40 731 796 US dollars.

Week Month 3 months Year 3 years

Nymox Pharmaceutical Corporation capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
04/05/2023 40 731 796 $
03/05/2023 38 921 496 $
02/05/2023 37 980 140 $
01/05/2023 33 490 588 $
28/04/2023 38 876 240 $
27/04/2023 41 636 948 $
26/04/2023 41 636 948 $

Nymox Pharmaceutical Corporation volume chart

Week Month 3 months Year 3 years

Nymox Pharmaceutical Corporation volume history data

Date Volume (24h)
Volume of trade of Nymox Pharmaceutical Corporation - total sum in US dollars for all deals with NYMX stocks bought and sold during selected date.
04/05/2023 2 034 $
03/05/2023 93 007 $
02/05/2023 2 960 $
01/05/2023 20 733 $
28/04/2023 67 621 $
27/04/2023 1 393 $
26/04/2023 11 330 $

Nymox Pharmaceutical Corporation capitalization in US dollars today 04/05/2023. 03/05/2023 Nymox Pharmaceutical Corporation market capitalization is equal to 38 921 496 US dollars. Nymox Pharmaceutical Corporation capitalization at 02/05/2023 is equal to 37 980 140 US dollars. The market capitalization of Nymox Pharmaceutical Corporation amounted to 33 490 588 US dollars at 01/05/2023.

28/04/2023 Nymox Pharmaceutical Corporation market capitalization is equal to 38 876 240 US dollars. Nymox Pharmaceutical Corporation capitalization at 27/04/2023 amounted to 41 636 948 US dollars. The market capitalization of Nymox Pharmaceutical Corporation at 26/04/2023 amounted to 41 636 948 US dollars.

Nymox Pharmaceutical Corporation capitalization is 40 731 796 $ now. Market capitalization of Nymox Pharmaceutical Corporation changed by +4.65% since yesterday. Today's volume of trade of NYMX stocks was 2 034 $. NYMX volume of trade amount changed to -97.813% since yesterday.

Nymox Pharmaceutical Corporation stocks data

Nymox Pharmaceutical Corporation financials